Decibel Therapeutics Inc. (DBTX)

AI Score

Unlock

4.91

-0.04 (-0.81%)

At close: Sep 22, 2023, 8:00 PM

4.91

0.00%

After-hours: Sep 22, 2023, 04:11 PM EDT

Decibel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	39.8M	38.06M	34.61M	36.68M	56.45M	10.78M	36.45M	51.41M	37.69M	52.24M	27.74M	5.2M	18.6M
Short-Term Investments	38.5M	49.88M	69.95M	75.26M	69.2M	123.66M	112.29M	92.48M	118.08M	129.84M	26.57M	n/a	13.71M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	5M	13.55M	28.49M	28.83M	9M	n/a	n/a	n/a
Other Long-Term Assets	934K	924K	924K	1.06M	1.16M	1.13M	1.13M	1.13M	1.13M	1.38M	3.12M	1.54M	1.44M
Receivables	n/a	4.4M	n/a	10M	10M	10M	11.4M	3.14M	1.72M	4.24M	1.24M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.15M	3.53M	3.47M	4.34M	5.76M	6.8M	4.04M	2.83M	3.81M	4.42M	2.28M	1.51M	1.26M
Total Current Assets	80.45M	95.87M	108.03M	126.29M	141.41M	151.24M	164.19M	149.87M	161.3M	190.73M	57.83M	6.71M	33.57M
Property-Plant & Equipment	13M	13.66M	14.42M	14.93M	15.71M	16.41M	5.61M	5.8M	5.63M	5.97M	6.34M	6.61M	7.83M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.94M	14.59M	15.34M	15.99M	16.87M	22.54M	20.29M	35.42M	35.59M	16.35M	9.46M	8.15M	9.26M
Total Assets	94.39M	110.45M	123.37M	142.27M	158.28M	173.78M	184.48M	185.29M	196.9M	207.09M	67.28M	14.86M	42.84M
Account Payables	617K	1.28M	1.06M	3.03M	1.92M	1.21M	4.01M	1.81M	2.14M	1M	2.13M	1.19M	1.01M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13.8M	16.86M	10.21M	n/a
Short-Term Debt	3.66M	3.59M	3.59M	3.62M	3.65M	3.68M	213K	208K	201K	197K	193K	318K	n/a
Other Current Liabilities	22.3M	18.31M	17.79M	16.72M	17.31M	13.22M	16.31M	14.48M	14.29M	197K	193K	318K	8.44M
Total Current Liabilities	26.58M	23.18M	22.44M	23.37M	22.87M	18.11M	20.54M	16.5M	16.64M	15.19M	19.37M	12.04M	9.45M
Long-Term Debt	9.18M	9.81M	10.47M	11.1M	11.73M	12.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.31M	7.62M	8.67M	10.98M	11.82M	15.23M	22.25M	14.63M	10.85M	11.63M	9.6M	12.81M	17.54M
Total Long-Term Liabilities	14.5M	17.43M	19.14M	22.09M	23.55M	27.56M	22.25M	14.63M	10.85M	11.63M	9.6M	12.81M	17.54M
Total Liabilities	41.08M	40.61M	41.58M	45.46M	46.42M	45.66M	42.79M	31.13M	27.48M	26.82M	229.97M	24.86M	26.99M
Total Debt	12.85M	13.4M	14.05M	14.72M	15.38M	16.01M	213K	208K	201K	197K	193K	318K	n/a
Common Stock	25K	25K	25K	25K	25K	25K	25K	25K	25K	25K	1K	n/a	n/a
Retained Earnings	-308.97M	-290.82M	-277.52M	-261.58M	-245.57M	-228.53M	-214.51M	-201.61M	-185.21M	-173.56M	-162.69M	-149.81M	-123.35M
Comprehensive Income	-35K	-61K	-223K	-503K	-588K	-527K	-132K	8K	5K	-21K	-1K	n/a	10K
Shareholders Equity	53.31M	69.84M	81.79M	96.81M	111.86M	128.12M	141.69M	154.16M	169.41M	180.27M	-162.69M	-9.99M	15.85M
Total Investments	38.5M	49.88M	69.95M	75.26M	69.2M	128.66M	125.84M	120.97M	146.91M	138.84M	26.57M	n/a	13.71M